How Circular Genomics is using genetics to stop depression meds being a guessing game

Katelyn Trinh
Aug 6, 2024
1 min read

NEW MEXICO (KRQE) – More Americans are suffering from depression, according to a Gallup study conducted in 2023. The study also found that minorities experience depression at twice the rate of white adults. New Mexico Frontier’s Chad Brummett spoke with one local company whose mission is to find solutions to this growing health crisis through genomic technology.

View Remaining Article on KRQE

Paul Sargeant, PhD, CEO of Circular Genomics Presents at LSI USA '25 - "Circular RNA Biomarkers for Depression Treatment"

Circular Genomics is at the forefront of revolutionizing healthcare by leveraging circular RNA to develop advanced diagnostic tools,...

5 Promising RNA Biotech Companies To Watch in 2025

Circular Genomics: Innovative RNA Solutions to Lead a New Era in Mental Health RNA, often referred to as the “messenger molecule,” plays...

Podcast: "Revolutionizing Depression Treatment with Dr. Nikolaos Mellios"

Circular Genomics' Chief Scientific Officer, Dr. Nikolaos Mellios, M.D., PhD, joins Steven Schwartz on the Concierge Medical Marketing...

Comments

Commenting on this post isn't available anymore. Contact the site owner for more info.